Zealand Pharma A/S (ZLDPY) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Zealand Pharma A/S ( ZLDPY ) Morgan Stanley 24th Annual Global Healthcare Conference September 16, 2026 11:30 AM EDT Company Participants Adam Steensberg - President & CEO Conference Call Participants James Machin Presentation James Machin Cool. Well, thank you all for being here. I'm James Machin from the Morgan Stanley banking team and delighted to have Adam from Zealand Pharma here this morning. I guess over the next 30, 35 minutes, we'll dive into a number of areas across the portfolio. But maybe to kick off, and start with a quick intro to yourself, maybe a short overview on what you're doing as a business, and then we can start to get into some of the detail. Adam Steensberg President & CEO Absolutely. Pleased to be here. And yes, Zealand Pharma is a Danish-founded company. We've been 27 years in the making, and we are on a journey towards becoming a leader in metabolic health. In December last year, we kicked off our new ambition, which is called the Metabolic Frontier 2030 with an ambition of having actually 5 products on the market in 2030, having a pipeline of 10 clinical programs and then also having industry-leading times from idea to clinic. So we are on a very, very, you can say, ambitious journey towards addressing what we believe is the biggest health care challenge of our time, not only the obesity pandemic we are seeing, but all the health consequences that follows obesity. So going beyond weight loss, looking into how we can help people improving their health span, living longer with a healthy life, the way people want to live their lives. That's what motivates us, and we are on a good journey towards delivering on that. Question-and-Answer Session James Machin Okay. Great. No, very exciting times for yourselves and for